RATIONALITY FOR THE USE OF ESSENTIAL PHOSPHOLIPIDS IN THE TREATMENT OF NAFLD


DOI: https://dx.doi.org/10.18565/pharmateca.2018.2.8-12

V.V. Tsukanov, A.V. Vasyutin, Yu.L. Tonkikh

Federal Research Center “Krasnoyarsk Scientific Center” of the Siberian Branch of the Russian Academy of Sciences” (FRC KSC SB RAS), “Scientific Research Institute of Medical Problems of the North “(SRI MPN), Krasnoyarsk, Russia
Analysis of current international and domestic recommendations allows to conclude that the leading non-medicinal methods for
treating non-alcoholic fatty liver disease include the use of a low-calorie diet with a sufficient content of polyunsaturated fats and graduated exercise to reduce body weight. Among the drugs, leading positions belong to insulin sensitizers, essential phospholipids (Essentiale Forte N) and antioxidants (vitamin E).
Keywords: non-alcoholic fatty liver disease, essential phospholipids

About the Autors


Corresponding author: V.V. Tsukanov – MD, Prof., Head of the Clinical Department of the Pathology of the Digestive System in Adults and Children FRC KSC SB RAS, SRI MPN, Krasnoyarsk, Russia; e-mail: gastro@impn.ru


Бионика Медиа